NHS National Generic Pharmaceuticals Wave 14b

Invitation to offer for NHS National Generic Pharmaceuticals Wave 14b

Offer reference number: CM/PHG/22/5668

Period of framework agreement: The total maximum duration of the framework agreement to be no more than 24 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.

Potential periods of call-offs under the framework agreement:

Orals (plus non-parenteral) Products All regions 01/10/2023 to 31/05/2024 (8 months)

Hospital Only Products: DCE & DSW regions 01/10/2023 - 30/09/2025 (24 months)

Housekeeping Products (Hospital Only):

DLN & DNW regions 01/10/2023 - 31/01/2025 (16 months)

DLS & DNE regions 01/10/2023 - 31/05/2024 (8 months)

Tender Documents

• Opportunity notice on Contracts Finder → — Tender notice
• Document No. 06 - Form of offer →
• Document No. 07a - Quality control technical sheet →
• Document No. 08 - Confidential information schedule →
• DOCUME~2 →
• Document No. 00 - Read Me First Document →
• Document No. 01 - Invitation to offer covering letter →
• Document No. 05a(i) - Product Listing and Usage - Orals (plus non-parenterals) Products CM_PHG_22_5668_01 →
• Document No. 02 - Terms of offer →
• Document No. 03 - Framework Agreement and Terms and Conditions →
• Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements →
• Document No. 05a(iii) - Product Listing and Usage - Hospital Only Products (DCE & DSW) CM_PHG_5668_02 →
• Document No. 09 - Stability Data Requirements →
• Document No. 05a(v) - Product Listing and Usage - Housekeeping Products (Hospital Only) CM_PHG_22_5668_03 →
• Document No. 05b - Selectt offer schedule instructions →